The global bird flu market is primarily driven by increasing prevalence of avian influenza virus strains among birds. Avian influenza, commonly called bird flu, refers to the disease caused by influenza A viruses. These viruses naturally infect wild aquatic birds and can infect domestic poultry and other bird and animal species. The avian influenza viruses circulate naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Most avian influenza viruses do not infect humans. However, sporadic human infections with avian influenza virus strains have occurred. The disease outcome in humans ranges from no symptoms or mild symptoms to severe disease.
The Global Bird Flu Market is estimated to be valued at US$ 3.21 Bn in 2024 and is expected to exhibit a CAGR of 4.6% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the global bird flu market are Stempeutics Research Pvt. Ltd., Medipost Co. Ltd., Nipro Corporation, Dendreon Pharmaceuticals LLC, Organogenesis Inc., Novartis AG, Vericel Corporation, Allogene Therapeutics Inc., Gilead Sciences Inc. (Kite Pharma Inc.), and Takeda Pharmaceutical Company Limited (TiGenix), among others. The rising prevalence of avian influenza viruses is the major factor fueling the demand for effective vaccines and therapeutics. Technological advancements such as development of viral propagation systems for large-scale vaccine production are helping companies meet the growing demand.
Global Bird Flu Market Growth consumer awareness regarding health security and increasing government funding for research on developing effective therapeutics against bird flu infections is fueling market growth. Various government organizations are focusing on building preparedness against possible pandemics which is expected to drive the demand for bird flu vaccines and anti-viral drugs over the forecast period.
Technological advancements in the areas of immunology and virology have enabled development of improved viral propagation systems for large-scale manufacturing of bird flu vaccines. Introduction of cell-based and recombinant DNA technologies has helped lower the production costs and accelerate the vaccine development process.
Market Trends
The global bird flu market is witnessing a growing preference for recombinant vaccines owing to their higher immunogenicity and safety profile as compared to conventional egg-based vaccines. Companies are concentrating on development of thermostable vaccines that do not require cold chain distribution and storage.
Adoption of single-dose vaccination regimes is another key trend being followed by manufacturers to improve patient compliance. Continuous monitoring of circulating avian influenza viruses helps update vaccine strains on a regular basis to keep up with evolving virus genetics.
Market Opportunities
Development of pan-reassortant or universal vaccines offering cross-protection against multiple virus strains presents significant growth opportunity. Growing research on therapeutic monoclonal antibodies and RNAi-based therapies active against avian influenza viruses also holds potential.
Global Bird Flu Market Regional Analysis is Public-private partnerships for pandemic preparedness programs in developing nations can further help strengthen preventive measures as well as product development initiatives. Technologies such as reverse genetics help accelerate the research and development process and reduce costs.
Impact of COVID-19 on the Global Bird Flu Market
The outbreak of the COVID-19 pandemic has negatively impacted the growth of the global bird flu market. Various factors such as restrictions on international trade, temporary shutdown of manufacturing facilities, and disruptions in the supply chain networks hampered market growth during the pandemic. As many parts of the world went under lockdown to curb the spread of the virus, production and distribution of bird flu drugs and vaccines also suffered. Researchers had to redirect resources from bird flu R&D projects to coronavirus vaccine development efforts. This further slowed down product launches and clinical trials for bird flu treatment.
However, post pandemic there are opportunities for market growth. With economies opening up, manufacturing and trade activities are resuming slowly. Companies are also strategizing to strengthen preparedness for future infectious disease outbreaks. Governments and international health organizations are increasing focus and funding for infectious disease monitoring, research and prevention. Increased awareness about infectious diseases among public and stakeholders is also driving demand for effective bird flu drugs and vaccines. But, supply chain disruptions and uncertain economic conditions continue to pose challenges. Sustained R&D investments and global collaboration will be crucial for the market to gain momentum in the coming years.
In terms of geographical concentration, North America holds a major share of the global bird flu market in terms of value, due to high awareness, advanced healthcare infrastructure and presence of key market players.
However, Asia Pacific is emerging as the fastest growing regional market with increasing government support for flu research, availability of low-cost manufacturing facilities and rising healthcare expenditures in countries like China and India. South East Asian countries remain highly vulnerable to avian influenza outbreaks as well due to migratory bird routes, requiring stronger preventive measures and local vaccine production capabilities. Africa also needs to build flu surveillance and response capacities considering shared risks with Asia and Europe. Overall, globally coordinated efforts are essential for effective bird flu control.
Get more insights on, Global Bird Flu Market
Explore More Related Article On- Gastroesophageal Reflux Disease Treatment Devices Market
For Deeper Insights, Find the Report in the Language that You want.
About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement. (LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)
Comments on “The Global Bird Flu Market will grow at highest pace owing to rising government initiatives for bird flu vaccine development”